Abstract
Heparin, a sulfated polysaccharide, has been used as a clinical anticoagulant for over 90 years. Newer anticoagulants, introduced for certain specialized applications, have not significantly displaced heparin and newer heparin-based anticoagulants in most medical procedures. This chapter, while reviewing anticoagulation and these newer anticoagulants, focuses on heparin-based anticoagulants, including unfractionated heparin, low molecular weight heparins and ultra-low molecular weight heparins. Heparin's structures and its biological and therapeutic roles are discussed. Particular emphasis is placed on heparin's therapeutic application and its adverse effects. The future prospects are excellent for new heparins and new heparin-based therapeutics with improved properties.
| Original language | English |
|---|---|
| Pages (from-to) | 1372-1392 |
| Number of pages | 21 |
| Journal | Frontiers in Bioscience - Landmark |
| Volume | 21 |
| Issue number | 7 |
| DOIs | |
| State | Published - 1 Jun 2016 |
| Externally published | Yes |
Keywords
- Anticoagulants
- Anticoagulation
- Bioengineered heparin
- Bovine heparin
- Heparin
- Review
Fingerprint
Dive into the research topics of 'Heparin and anticoagulation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver